#nucleoside — Monday, February 09, 2026 (1 items)
| 0 | ℹ |
Efficacy and Safety of Obeldesivir in High-Risk Nonhospitalized Patients With COVID-19 (BIRCH): A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study.
(academic.oup.com)
|
Clinical Infectious Diseases 2026-02-09 | #covid-19 #clinical trial #antiviral #nucleoside |